Related Experiment Video
Updated: Jul 12, 2026
07:35
Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
Resveratrol Ameliorates PTZ-Induced Seizure Activity and Diaphragm Muscle Dysfunction by Regulating Calcium Handling
Ahmet Akkoca1, Ömer Ünal2, Nilüfer Akgün-Ünal3
1Department of Biophysics, Faculty of Medicine, University of Necmettin Erbakan, Konya, Türkiye. aakkoca@erbakan.edu.tr.
Molecular Neurobiology
|July 9, 2026
Summary
Epilepsy significantly weakens diaphragm function by disrupting calcium balance and increasing cell death. Resveratrol treatment shows promise in restoring diaphragm mechanics and function in epilepsy models.
Area of Science:
- Neurology
- Muscle Physiology
- Pharmacology
Background:
- Epilepsy is a common neurological disorder with potential systemic effects.
- Diaphragm muscle dysfunction is a recognized complication of chronic epilepsy.
- Calcium homeostasis and apoptosis play critical roles in muscle function.
Purpose of the Study:
- To investigate the chronic impact of epilepsy on diaphragm muscle function.
- To evaluate the therapeutic potential of resveratrol in mitigating these effects.
- To elucidate the molecular mechanisms underlying resveratrol's action.
Main Methods:
- Adult male Wistar rats were divided into Sham, resveratrol, pentylenetetrazol (PTZ)-induced epilepsy, and PTZ+resveratrol groups.
- Seizure activity was monitored using electrocorticography (ECoG).
- Diaphragm contractility, fatigue, calcium levels, Atp2a2 expression, and apoptotic markers were assessed.
Main Results:
- Chronic seizures significantly impaired diaphragm contractility and induced fatigue.
- Seizure-induced diaphragm dysfunction was linked to Atp2a2 inhibition, calcium overload, and increased apoptosis.
- Resveratrol treatment improved diaphragm mechanical activity and fatigue resistance.
- Resveratrol's effects were associated with normalized calcium homeostasis and reduced apoptosis.
Conclusions:
- Epilepsy leads to diaphragm dysfunction through impaired calcium handling and apoptosis.
- Resveratrol demonstrates therapeutic potential by restoring diaphragm function in epilepsy.
- Resveratrol exerts its beneficial effects by regulating calcium homeostasis, Atp2a2 activity, and apoptosis.
Related Concept Videos
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...